Vol. 19 No. 3 (2023): May/June

Published: 19-04-2023

Articles

Understanding the relationship between domestic and intimate partner violence, adverse childhood experiences, and chronic opioid use disorder: The patient perspective

Heather F. Thiesset, PhD, MPH, Melinda Barber, MS, Braydonn Moore, Amelia Van Komen, AliceAnn Crandall, PhD

195-204
- Requires Subscription or Fee PDF (USD 56)
Predictors of opioid prescription among outpatients with osteoarthritis in the United States

Shrey Gohil, BPharm, Niaz Deyhim, PharmD, MS, BCPS, Osaro Mgbere, PhD, MS, MPH, Ekere James Essien, MD, DrPH, FRSPH

205-223
- Requires Subscription or Fee PDF (USD 56)
Estimating the prevalence and correlates of pain among people living with HIV who use unregulated drugs in a Canadian setting

Jane Loh, MSc, Jane Buxton, MBBS, MHSc, FRCPC, Angela Kaida, PhD, Pauline Voon, BSN, RN, Cameron Grant, BSc, M-J Milloy, PhD

225-237
- Requires Subscription or Fee PDF (USD 56)
Pharmacists’ perspectives on opioid stewardship challenges

Kristina L. Westcott, PharmD, BCPS, Andrea K. Swanson, RPh, Kathryn W. Zavaleta, MHSA, Halena M. Gazelka, MD, Lindsey M. Philpot, PhD, Julie L. Cunningham, PharmD, RPh

239-245
- Requires Subscription or Fee PDF (USD 56)
Implementation of required sedation assessment in nursing workflow to address naloxone utilization

Edward Hardison, MD, Ainsley Bloomer, MD, Meghan K. Wally, PhD, Erica McArthur, MD, Joseph R. Hsu, MD, Susan Bear, PharmD, Steven Jarrett, PharmD, Tamar Roomian, MS, MPH, D. Matthew Sullivan, MD, Karon Wold, MSN, Ziqing Yu, MS, Susan Odum, PhD, Rachel B. Seymour, PhD

247-255
- Requires Subscription or Fee PDF (USD 56)
Tramadol utilization among patients with higher risk of adverse drug events: A claims analysis of commercially insured and Medicare Advantage members

Eric P. Borrelli, PhD, PharmD, MBA, Jeffrey Bratberg, PharmD, FAPhA, Mary L. Greaney, PhD, MPH, Stephen J. Kogut, PhD, MBA, RPh

257-271
- Requires Subscription or Fee PDF (USD 56)
Efficacy and tolerability of oral morphine versus oxycodone/acetaminophen for analgesia in the emergency department

Hayley Harvey, MD, Maria Cacciapuoti, MD, Leena Ramadan, MD, Katherine Brodie, MD, Colin Gibson, MD, Eshetu Tefera, MS, Gregory G. Yu, MD, PharmD, MBA, MPH, Sergey M. Motov, MD, Lewis S. Nelson, MD, Maryann Mazer-Amirshahi, PharmD, MD, MPH, PhD

273-280
- Requires Subscription or Fee PDF (USD 56)

Full Issue

Volume 19, Number 3

191-280

Vol. 19 No. 3 (2023): May/June

Articles

Understanding the relationship between domestic and intimate partner violence, adverse childhood experiences, and chronic opioid use disorder: The patient perspective

Predictors of opioid prescription among outpatients with osteoarthritis in the United States

Estimating the prevalence and correlates of pain among people living with HIV who use unregulated drugs in a Canadian setting

Pharmacists’ perspectives on opioid stewardship challenges

Implementation of required sedation assessment in nursing workflow to address naloxone utilization

Tramadol utilization among patients with higher risk of adverse drug events: A claims analysis of commercially insured and Medicare Advantage members

Efficacy and tolerability of oral morphine versus oxycodone/acetaminophen for analgesia in the emergency department

Full Issue

Volume 19, Number 3

Subscription

Information

Announcements